Opportunity to contribute to an important health issue, The role focuses on bowel cancer screening and surveillance for people with cystic fibrosis, making a direct impact on patient care and outcomes.
Collaborative environment, Work closely with renowned academics and clinical colleagues, providing an enriching team experience and professional development.
Focus on qualitative research, Ideal for candidates passionate about qualitative methodologies and exploring in-depth insights into healthcare practices.
Flexibility, The part-time nature of the job (0.6FTE) with provisions for flexible working allows for a better work-life balance.
Professional growth, Engaging in data analysis, conducting interviews, and participating in the dissemination of findings enhance research skills and career progression.
Generous benefits package, Includes pension schemes, excellent holiday entitlements, reduced study fees, and subsidised fitness facilities, fostering employee well-being.
Inclusive workplace, The role actively encourages applications from under-represented groups, promoting diversity and inclusion within the research community.
Join Leeds Beckett University as a Research Officer and make a meaningful impact in healthcare! This part-time role (0.6FTE) offers you the chance to dive into a vital qualitative interview study, focusing on bowel cancer screening for individuals with cystic fibrosis (CF). If you’re passionate about patient outcomes and want to work alongside leading experts like Professor Laura Ashley, this could be the opportunity you've been waiting for. You'll play a key role in recruiting and interviewing patients and healthcare professionals, plus contribute to data analysis and sharing critical insights that can enhance care practices.
This 18-month fixed-term position, starting on 1st April 2025, offers flexibility, including the option for some home-based work to help balance your commitments. We understand that women and caregivers often navigate unique challenges in their careers, and we’re committed to providing a supportive and adaptable work environment. With a range of benefits from generous holiday allowances to excellent pension schemes, you'll find a workplace that values your contributions. We encourage applications from all backgrounds, especially those from black and minority ethnic communities, as we aim for a diverse and inclusive team. Ready to take the next step? For an informal chat, reach out to Professor Laura Ashley at L.J.Ashley@leedsbeckett.ac.uk. Apply by 24th March 2025!
This 18-month fixed-term position, starting on 1st April 2025, offers flexibility, including the option for some home-based work to help balance your commitments. We understand that women and caregivers often navigate unique challenges in their careers, and we’re committed to providing a supportive and adaptable work environment. With a range of benefits from generous holiday allowances to excellent pension schemes, you'll find a workplace that values your contributions. We encourage applications from all backgrounds, especially those from black and minority ethnic communities, as we aim for a diverse and inclusive team. Ready to take the next step? For an informal chat, reach out to Professor Laura Ashley at L.J.Ashley@leedsbeckett.ac.uk. Apply by 24th March 2025!
Opportunity to contribute to an important health issue, The role focuses on bowel cancer screening and surveillance for people with cystic fibrosis, making a direct impact on patient care and outcomes.
Collaborative environment, Work closely with renowned academics and clinical colleagues, providing an enriching team experience and professional development.
Focus on qualitative research, Ideal for candidates passionate about qualitative methodologies and exploring in-depth insights into healthcare practices.
Flexibility, The part-time nature of the job (0.6FTE) with provisions for flexible working allows for a better work-life balance.
Professional growth, Engaging in data analysis, conducting interviews, and participating in the dissemination of findings enhance research skills and career progression.
Generous benefits package, Includes pension schemes, excellent holiday entitlements, reduced study fees, and subsidised fitness facilities, fostering employee well-being.
Inclusive workplace, The role actively encourages applications from under-represented groups, promoting diversity and inclusion within the research community.
Job Description
You are invited to apply for the role of Research Officer on a qualitative interview study, funded by Bowel Research UK and Cystic Fibrosis Trust, examining bowel cancer screening and surveillance for people with cystic fibrosis (CF).
This is an exciting opportunity for someone passionate about qualitative research that aims to improve health care and patient outcomes. You will work closely with the Principal Investigator, Professor Laura Ashley, and with the wider research team of academic and clinical colleagues including Professor Daniel Peckham and Dr Mo Thoufeeq.
As the study Research Officer you will be a key member of the team supporting day-to-day management and delivery of the research project. Your main duties will include recruiting and interviewing people with CF and health care professionals, leading on data analysis, and contributing to write-up and dissemination of the findings.
People with CF have a higher risk of developing bowel cancer, and at a younger age. Bowel cancer screening and surveillance can prevent bowel cancers by removing pre-cancerous cells and catch bowel cancers early when more treatable. People with CF require more intensive bowel cancer screening than standard provision; the CF Foundation recommends colonoscopy screening from age 40. CF care teams have begun to introduce tailored bowel cancer screening and surveillance, but provision is unequal and underdeveloped. Interviews will examine the challenges and needs of clinicians and patients around providing and receiving CF-tailored bowel cancer screening and surveillance information, support, and care, and ways to address these.
This is a part-time role (60%FTE) for 18 months, starting 1st April 2025 (or as soon as possible thereafter) until 30th September 2026. Flexible working (e.g., some home-based working) is permitted provided the requirements of the job can be met.
For an informal chat about this role, please contact Professor Laura Ashley at .
Closing date Monday 24th March 2025 (2359)
Working here means you’ll also have access to a wide range of benefits including our generous pension schemes, excellent holiday entitlements, flexible working, reduced study fees, subsidised fitness facilities and a lot more.
We welcome applications from all individuals and particularly from black and minority ethnic candidates as members of these groups are currently under-represented at this level of post. All appointments will be based on merit.
Apply online
Send to a friend
You are invited to apply for the role of Research Officer on a qualitative interview study, funded by Bowel Research UK and Cystic Fibrosis Trust, examining bowel cancer screening and surveillance for people with cystic fibrosis (CF).
This is an exciting opportunity for someone passionate about qualitative research that aims to improve health care and patient outcomes. You will work closely with the Principal Investigator, Professor Laura Ashley, and with the wider research team of academic and clinical colleagues including Professor Daniel Peckham and Dr Mo Thoufeeq.
As the study Research Officer you will be a key member of the team supporting day-to-day management and delivery of the research project. Your main duties will include recruiting and interviewing people with CF and health care professionals, leading on data analysis, and contributing to write-up and dissemination of the findings.
People with CF have a higher risk of developing bowel cancer, and at a younger age. Bowel cancer screening and surveillance can prevent bowel cancers by removing pre-cancerous cells and catch bowel cancers early when more treatable. People with CF require more intensive bowel cancer screening than standard provision; the CF Foundation recommends colonoscopy screening from age 40. CF care teams have begun to introduce tailored bowel cancer screening and surveillance, but provision is unequal and underdeveloped. Interviews will examine the challenges and needs of clinicians and patients around providing and receiving CF-tailored bowel cancer screening and surveillance information, support, and care, and ways to address these.
This is a part-time role (60%FTE) for 18 months, starting 1st April 2025 (or as soon as possible thereafter) until 30th September 2026. Flexible working (e.g., some home-based working) is permitted provided the requirements of the job can be met.
For an informal chat about this role, please contact Professor Laura Ashley at .
Closing date Monday 24th March 2025 (2359)
Working here means you’ll also have access to a wide range of benefits including our generous pension schemes, excellent holiday entitlements, flexible working, reduced study fees, subsidised fitness facilities and a lot more.
We welcome applications from all individuals and particularly from black and minority ethnic candidates as members of these groups are currently under-represented at this level of post. All appointments will be based on merit.
Apply online
Send to a friend
More information related to this job opportunity, from jobsincare:
Possible interview questions for this job
Click to
viewStart practice interview
NEW!
Please wait...this will take a moment...
Please wait...this will take a moment...
More about CANCER
Cancer remains one of the most significant health challenges in the United Kingdom, impacting millions of lives each year. According to Cancer Research UK, nearly one in two people in the UK will be diagnosed with cancer at some point in their lifetime, highlighting the pervasive nature of this disease.Learn more...
More about CYSTIC FIBROSIS
Cystic Fibrosis (CF) is a hereditary genetic disorder that primarily affects the lungs and digestive system. In the United Kingdom, CF remains one of the most common life-threatening genetic conditions, with approximately 10,500 people living with the illness. Understanding CF's implications for individuals and society, along with advancements in treatment, is crucial for improving the lives of those affected.Learn more...
inLeeds
What might it look like to work here?
Stand by, we'll show you...
Stand by, we'll show you...
This image is not representative.
Learn more